Paper Details

  1. Home
  2. Paper Details

A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma.

Author: AndersenJens, BernsteinDavid, GawchikSandra, MurphyKevin, PedersenMartin Rud

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study evaluated grass allergy immunotherapy tablet (AIT) treatment in adults with grass pollen-induced allergic rhinitis.
Paper Details　
Original Abstract of the Article :
Design and execution of immunotherapy trials for seasonal allergies may be complicated by numerous factors including variable allergy testing methods, pollen levels, and timing and intensity of other seasonal allergens. We evaluated grass allergy immunotherapy tablet (AIT) treatment in North America...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689082/

データ提供：米国国立医学図書館（NLM）

Grass Allergy Immunotherapy: A Promising Path to Relief from Seasonal Allergic Rhinitis

This research focuses on the development of a new immunotherapy tablet for treating grass allergy-induced allergic rhinitis, a common seasonal ailment. The authors conducted a phase 3 clinical trial to evaluate the efficacy and safety of this tablet in adults experiencing symptoms of allergic rhinitis, with or without conjunctivitis and asthma. The study design aimed to address the complexities inherent in immunotherapy trials for seasonal allergies, considering factors like variable allergy testing methods and fluctuating pollen levels.

Harnessing the Power of Immunotherapy: A New Frontier in Allergy Treatment

This research presents promising findings for individuals suffering from grass allergies. The study demonstrated the potential of a grass allergy immunotherapy tablet to effectively alleviate symptoms of allergic rhinitis. The study's focus on a North American population, considering regional pollen variations, adds valuable insight into the practicality and efficacy of this treatment approach.

Finding Relief from Seasonal Allergies: A Path to Better Living

The study's findings offer hope for individuals seeking relief from the debilitating symptoms of grass allergy-induced allergic rhinitis. This research highlights the importance of ongoing research into immunotherapy as a potential treatment option for various types of allergies. It's important to consult with a healthcare professional to determine if immunotherapy is an appropriate option for your individual situation.

Dr. Camel's Conclusion

This research takes us on a journey through the pollen-filled landscapes of seasonal allergies, showcasing the potential of immunotherapy tablets to provide relief. Just as a camel adapts to the harsh desert environment, immunotherapy aims to help individuals adapt to their allergic sensitivities, offering a path to a more comfortable life.

Date :
  1. Date Completed 2015-03-30
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

23725348

DOI: Digital Object Identifier

PMC3689082

Related Literature

Article Analysis
・Effective treatment of seasonal allergies
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.